• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨曲南用于治疗儿科患者的需氧革兰氏阴性杆菌感染。

Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.

作者信息

Trujillo H, Harry N, Arango A, Benítez G, Restrepo F, Mejía G I, Castrillón A L

机构信息

Corporación para Investigaciones Biológicas, Medellin, Colombia.

出版信息

Chemotherapy. 1989;35 Suppl 1:25-30. doi: 10.1159/000238717.

DOI:10.1159/000238717
PMID:2731447
Abstract

Aztreonam was administered to 20 children diagnosed as having any of the following infections: urinary tract infection, pneumonia, meningitis, and abscess of the appendix. Haemophilus influenzae, Escherichia coli, and Klebsiella pneumoniae were isolated. The minimum inhibitory concentrations of aztreonam for these bacteria ranged from 0.03 to 0.5 micrograms/ml. All patients were clinically and bacteriologically cured within 5-16 days of treatment. Six months after completion of therapy, patients who had had meningitis appeared to be free of any neurologic sequelae. The antibiotic was well tolerated by all patients.

摘要

氨曲南用于治疗20名被诊断患有以下任何一种感染的儿童:尿路感染、肺炎、脑膜炎和阑尾脓肿。分离出了流感嗜血杆菌、大肠杆菌和肺炎克雷伯菌。氨曲南对这些细菌的最低抑菌浓度范围为0.03至0.5微克/毫升。所有患者在治疗5至16天内临床和细菌学上均治愈。治疗结束6个月后,曾患脑膜炎的患者似乎没有任何神经后遗症。所有患者对该抗生素耐受性良好。

相似文献

1
Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.氨曲南用于治疗儿科患者的需氧革兰氏阴性杆菌感染。
Chemotherapy. 1989;35 Suppl 1:25-30. doi: 10.1159/000238717.
2
Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.氨曲南治疗革兰阴性菌脑膜炎及其他革兰阴性菌感染。
Chemotherapy. 1989;35 Suppl 1:31-8. doi: 10.1159/000238718.
3
Successful response of severe neonatal gram-negative infection to treatment with aztreonam.严重新生儿革兰氏阴性菌感染对氨曲南治疗的成功反应。
Chemotherapy. 1989;35 Suppl 1:101-5. doi: 10.1159/000238727.
4
Aztreonam in gram-negative infections in children.氨曲南用于儿童革兰氏阴性菌感染
Chemioterapia. 1987 Jun;6(2 Suppl):415-7.
5
The use of aztreonam in pediatric patients: a review.
Pharmacotherapy. 1991;11(1):20-5.
6
Aztreonam therapy for serious gram-negative infections in children.氨曲南治疗儿童严重革兰氏阴性菌感染
Am J Dis Child. 1986 Nov;140(11):1147-51. doi: 10.1001/archpedi.1986.02140250073038.
7
Aztreonam in the treatment of gram-negative bacterial meningitis.氨曲南治疗革兰氏阴性菌脑膜炎。
Rev Infect Dis. 1991 May-Jun;13 Suppl 7:S586-90. doi: 10.1093/clinids/13.supplement_7.s586.
8
Aztreonam for treating meningitis caused by gram-negative rods.氨曲南用于治疗革兰氏阴性杆菌引起的脑膜炎。
Scand J Infect Dis. 1991;23(1):125-6. doi: 10.3109/00365549109023387.
9
Aztreonam therapy for serious gram-negative bacillary infections.
Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S794-802. doi: 10.1093/clinids/7.supplement_4.s794.
10
Aztreonam in the treatment of bacterial meningitis.氨曲南治疗细菌性脑膜炎。
Chemotherapy. 1989;35 Suppl 1:39-44. doi: 10.1159/000238719.